Sichuan Neautus TCM Files for Hong Kong IPO to Accelerate Domestic and Global Expansion
HONG KONG, Sep 3, 2025 – (ACN Newswire via SeaPRwire.com) – Company leverages dual-market strategy and technology-driven standardization to strengthen its leadership in China’s TCM sector and enter international markets.Sichuan Neautus Traditional Chinese Medicine Co., Ltd. has submitted a listing application to the Hong Kong Stock Exchange. The IPO is intended to raise capital to support the company’s expansion both domestically and internationally amid rapid modernization of China’s traditional Chinese medicine (TCM) industry.Founded in 2021, Chengdu, China, Neautus has grown into a leading player in the herbal decoction pieces market, with annual revenue exceeding RMB 1.2 billion.Dual Growth EnginesNeautus operates a “dual-engine” growth model, balancing institutional sales and consumer demand.The company supplies more than 1,000 major hospitals in China and is continuing to grow. And through its B2B platform, “Jinfang Caotang,” which is an online platform aimed at meeting the demands of approximately 90,…